Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Acer replaces Asustek as No. 5 PC brand in Q1: Gartner
04/19/2025 04:17 PM - Politics
Taiwan to release details on package addressing tariff shock next week
04/19/2025 03:42 PM - Business
Taiwan could stay on U.S. currency monitoring list: Central bank
04/19/2025 03:11 PM - Politics
KMT to hold assembly on April 26 in protest against President Lai
04/19/2025 01:52 PM - Society
Temperature highs could hit 35°C in southern Taiwan on Saturday
04/19/2025 11:54 AM